Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Bovine, Dog, Horse, Cat, Human, Mustelid, Mink, Non-human primate, Pig, Rabbit|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG2b|
|Immunogen||Human platelet membrane.|
|Contains||0.09% sodium azide|
|Storage Conditions||4°C or -20°C if preferred|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1/100 - 1/200|
|Immunohistochemistry (Frozen) (IHC (F))||1/500 - 1/1000|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Miscellaneous PubMed (MISC)||See 1 publications below|
Predicted to react with mustelid based on sequence homology.
For FACS analysis, use 10ul of the suggested working dilution to label 1x10^6 cells in 100ul.
The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It can modulate cell adhesion and migration and also trigger platelet activation and aggregation. In addition, the protein appears to promote muscle cell fusion and support myotube maintenance.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
MA1-80307 was used in flow cytometry and western blot to investigate the role of CD9 in the cell adhesion-mediated drug resistance mechanism of small cell lung cancer
|Kohmo S,Kijima T,Otani Y,Mori M,Minami T,Takahashi R,Nagatomo I,Takeda Y,Kida H,Goya S,Yoshida M,Kumagai T,Tachibana I,Yokota S,Kawase I||Cancer research (70:8025)||2010|
5H9; 5H9 antigen; antigen CD9; BA-2/p24 antigen; BA2; BTCC-1; CD9; CD9 antigen; CD9 antigen (p24); Cell growth-inhibiting gene 2 protein; DRAP-27; GIG2; Leukocyte antigen MIC3; MIC3; motility related protein-1; Motility-related protein; MRP-1; P24; Tetraspanin-29; transmembrane protein CD9-like; TSPAN-29
BOS_6044; BTCC-1; CD9; DRAP-27; GIG2; MIC3; MRP-1; TSPAN-29; TSPAN29